ARS Pharmaceuticals, Inc. (SPRY) stock
SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.69+0.04 (+1.10%)
Close on Nov 18, 2026Market cap $366.96MP/E –Yield –
ARS Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2023 it was $30.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $30.00K | – |
See a number that looks wrong?